Hillsdale Investment Management Inc. Bristol Myers Squibb CO Transaction History
Hillsdale Investment Management Inc.
- $1.79 Billion
- Q4 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 14,000 shares of BMY stock, worth $781,620. This represents 0.04% of its overall portfolio holdings.
Number of Shares
14,000
Previous 400
3400.0%
Holding current value
$781,620
Previous $20,000
3855.0%
% of portfolio
0.04%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...